Gymnemic Acids Inhibit Hyphal Growth and Virulence in Candida albicans
Open Access
- 11 September 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (9), e74189
- https://doi.org/10.1371/journal.pone.0074189
Abstract
Candida albicans is an opportunistic and polymorphic fungal pathogen that causes mucosal, disseminated and invasive infections in humans. Transition from the yeast form to the hyphal form is one of the key virulence factors in C. albicans contributing to macrophage evasion, tissue invasion and biofilm formation. Nontoxic small molecules that inhibit C. albicans yeast-to-hypha conversion and hyphal growth could represent a valuable source for understanding pathogenic fungal morphogenesis, identifying drug targets and serving as templates for the development of novel antifungal agents. Here, we have identified the triterpenoid saponin family of gymnemic acids (GAs) as inhibitor of C. albicans morphogenesis. GAs were isolated and purified from Gymnema sylvestre leaves, the Ayurvedic traditional medicinal plant used to treat diabetes. Purified GAs had no effect on the growth and viability of C. albicans yeast cells but inhibited its yeast-to-hypha conversion under several hypha-inducing conditions, including the presence of serum. Moreover, GAs promoted the conversion of C. albicans hyphae into yeast cells under hypha inducing conditions. They also inhibited conidial germination and hyphal growth of Aspergillus sp. Finally, GAs inhibited the formation of invasive hyphae from C. albicans-infected Caenorhabditis elegans worms and rescued them from killing by C. albicans. Hence, GAs could be useful for various antifungal applications due to their traditional use in herbal medicine.Keywords
This publication has 55 references indexed in Scilit:
- Coevolution of Morphology and Virulence in Candida SpeciesEukaryotic Cell, 2011
- The Quorum-Sensing Molecules Farnesol/Homoserine Lactone and Dodecanol Operate via Distinct Modes of Action in Candida albicansEukaryotic Cell, 2011
- Modulation of Morphogenesis in Candida albicans by Various Small MoleculesEukaryotic Cell, 2011
- Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicityNature Genetics, 2010
- Characterization of Plant-Derived Saponin Natural Products against Candida albicansACS Chemical Biology, 2010
- Candida albicans Hyphal Formation and Virulence Assessed Using a Caenorhabditis elegans Infection ModelEukaryotic Cell, 2009
- Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance RegistryClinical Infectious Diseases, 2009
- Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulenceProceedings of the National Academy of Sciences of the United States of America, 2009
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- A Recombinant Attenuated Salmonella enterica Serovar Typhimurium Vaccine Encoding Eimeria acervulina Antigen Offers Protection against E. acervulina ChallengeInfection and Immunity, 2006